Filmon Solomon

Filmon is a seasoned chemist with a Master's degree from Stockholm University and over 15 years of experience in the biotech industry. He possesses a unique combination of scientific and commercial expertise. As the founder and CEO of Sarcomed, a specialty pharmaceutical company dedicated to developing repurposed drugs for rare muscular dystrophies, Filmon has been instrumental in advancing treatments for these conditions. He has secured multiple FDA Orphan Drug Designations and has worked extensively with both the EMA and FDA on various projects, including NDA and IND submissions for several orphan drugs. Filmon's extensive background in drug development and regulatory affairs significantly enriches the Cleracs team.